Literature DB >> 24956391

Near infrared spectroscopy (NIRS) as a new non-invasive tool to detect oxidative skeletal muscle impairment in children survived to acute lymphoblastic leukaemia.

Francesca Lanfranconi1, Luca Pollastri1, Alessandra Ferri1, Donatella Fraschini2, Giuseppe Masera2, Giuseppe Miserocchi1.   

Abstract

BACKGROUND: Separating out the effects of cancer and treatment between central and peripheral components of the O2 delivery chain should be of interest to clinicians for longitudinal evaluation of potential functional impairment in order to set appropriate individually tailored training/rehabilitation programmes. We propose a non-invasive method (NIRS, near infrared spectroscopy) to be used in routine clinical practice to evaluate a potential impairment of skeletal muscle oxidative capacity during exercise in children previously diagnosed with acute lymphoblastic leukaemia (ALL). The purpose of this study was to evaluate the capacity of skeletal muscle to extract O2 in 10 children diagnosed with ALL, 1 year after the end of malignancy treatment, compared to a control group matched for gender and age (mean±SD = 7.8±1.5 and 7.3±1.4 years, respectively). METHODS AND
FINDINGS: Participants underwent an incremental exercise test on a treadmill until exhaustion. Oxygen uptake ([Formula: see text]), heart rate (HR), and tissue oxygenation status (Δ[HHb]) of the vastus lateralis muscle evaluated by NIRS, were measured. The results showed that, in children with ALL, a significant linear regression was found by plotting [Formula: see text] vs Δ[HHb] both measured at peak of exercise. In children with ALL, the slope of the HR vs [Formula: see text] linear response (during sub-maximal and peak work rates) was negatively correlated with the peak value of Δ[HHb].
CONCLUSIONS: The present study proves that the NIRS technique allows us to identify large inter-individual differences in levels of impairment in muscle O2 extraction in children with ALL. The outcome of these findings is variable and may reflect either muscle atrophy due to lack of use or, in the most severe cases, an undiagnosed myopathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24956391      PMCID: PMC4067277          DOI: 10.1371/journal.pone.0099282

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  37 in total

Review 1.  Is physical fitness decreased in survivors of childhood leukemia? A systematic review.

Authors:  M van Brussel; T Takken; A Lucia; J van der Net; P J M Helders
Journal:  Leukemia       Date:  2005-01       Impact factor: 11.528

2.  Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography.

Authors:  M Hauser; B S Gibson; N Wilson
Journal:  Eur J Pediatr       Date:  2001-10       Impact factor: 3.183

Review 3.  Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.

Authors:  O Teuffel; S P Kuster; S P Hunger; V Conter; J Hitzler; M-C Ethier; P S Shah; J Beyene; L Sung
Journal:  Leukemia       Date:  2011-04-29       Impact factor: 11.528

4.  Lung function and exercise capacity in survivors of childhood leukaemia.

Authors:  M E Jenney; E B Faragher; P H Jones; A Woodcock
Journal:  Med Pediatr Oncol       Date:  1995-04

5.  [Exercise cardiorespiratory parameters in children motivated to physical activity after treatment for acute lymphoblastic leukemia].

Authors:  H Vizinová; J Malincíková; E Klásková; J Wiedermann
Journal:  Cas Lek Cesk       Date:  2002-08-02

6.  Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.

Authors:  A M Wallace; P Tucker; D M Williams; I A Hughes; S F Ahmed
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

7.  Patterns of domestic migrations and access to childhood cancer care centres in Italy: a report from the hospital based registry of the Italian Association of Pediatric Hematology and Oncology (AIEOP).

Authors:  Elisa Dama; Roberto Rondelli; Marisa De Rosa; Maurizio Aricò; Modesto Carli; Franca Fossati Bellani; Corrado Magnani; Franco Merletti; Guido Pastore; Andrea Pession
Journal:  Eur J Cancer       Date:  2008-08-20       Impact factor: 9.162

8.  Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.

Authors:  Maurizio Aricò; Maria Grazia Valsecchi; Carmelo Rizzari; Elena Barisone; Andrea Biondi; Fiorina Casale; Franco Locatelli; Luca Lo Nigro; Matteo Luciani; Chiara Messina; Concetta Micalizzi; Rosanna Parasole; Andrea Pession; Nicola Santoro; Anna Maria Testi; Daniela Silvestri; Giuseppe Basso; Giuseppe Masera; Valentino Conter
Journal:  J Clin Oncol       Date:  2008-01-10       Impact factor: 44.544

9.  Long term survivors of childhood cancer: cure and care. The Erice statement.

Authors:  Riccardo Haupt; John J Spinetta; Irina Ban; Ronald D Barr; Joern D Beck; Julianne Byrne; Gabriele Calaminus; Eva Coenen; Mark Chesler; Giulio J D'Angio; Christine Eiser; Andreas Feldges; Faith Gibson; Herwig Lackner; Giuseppe Masera; Luisa Massimo; Edina Magyarosy; Jacques Otten; Gregory Reaman; Maria Grazia Valsecchi; Anjo J P Veerman; Anthony Penn; Anne Thorvildsen; Cor van den Bos; Momcilo Jankovic
Journal:  Eur J Cancer       Date:  2007-05-31       Impact factor: 9.162

10.  Impaired oxygen extraction in metabolic myopathies: detection and quantification by near-infrared spectroscopy.

Authors:  Bruno Grassi; Mauro Marzorati; Francesca Lanfranconi; Alessandra Ferri; Miriam Longaretti; Andrea Stucchi; Paola Vago; Claudio Marconi; Lucia Morandi
Journal:  Muscle Nerve       Date:  2007-04       Impact factor: 3.217

View more
  6 in total

1.  Single-trial lie detection using a combined fNIRS-polygraph system.

Authors:  M Raheel Bhutta; Melissa J Hong; Yun-Hee Kim; Keum-Shik Hong
Journal:  Front Psychol       Date:  2015-06-02

2.  Improving Peripheral and Central Vascular Adjustments during Exercise through a Training Program in Adolescents with Obesity.

Authors:  Valérie Julian; David Thivel; Bruno Pereira; Frédéric Costes; Ruddy Richard; Martine Duclos
Journal:  Obes Facts       Date:  2016-10-04       Impact factor: 3.942

3.  Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise.

Authors:  F Lanfranconi; A Ferri; G Corna; R Bonazzi; C Lunetta; V Silani; N Riva; A Rigamonti; A Maggiani; C Ferrarese; L Tremolizzo
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

4.  The Impact of a Precision-Based Exercise Intervention in Childhood Hematological Malignancies Evaluated by an Adapted Yo-Yo Intermittent Recovery Test.

Authors:  William Zardo; Emanuele Villa; Eleonora Corti; Tommaso Moriggi; Giorgia Radaelli; Alessandra Ferri; Mauro Marzorati; Cristiano Eirale; Paola Vago; Andrea Biondi; Momcilo Jankovic; Adriana Balduzzi; Francesca Lanfranconi
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

5.  Exercise training and NR supplementation to improve muscle mass and fitness in adolescent and young adult hematopoietic cell transplant survivors: a randomized controlled trial {1}.

Authors:  Minkeun Song; Saro H Armenian; Rusha Bhandari; Kyuwan Lee; Kirsten Ness; Mary Putt; Lanie Lindenfeld; Saro Manoukian; Kristin Wade; Anna Dedio; Tati Guzman; Isabella Hampton; Kimberly Lin; Joseph Baur; Shana McCormack; Sogol Mostoufi-Moab
Journal:  BMC Cancer       Date:  2022-07-19       Impact factor: 4.638

6.  Osteopathic Treatment and Evaluation in the Clinical Setting of Childhood Hematological Malignancies.

Authors:  Monica Barbieri; William Zardo; Chiara Frittoli; Clara Rivolta; Valeria Valdata; Federico Bouquin; Greta Passignani; Alberto Maggiani; Momcilo Jankovic; Andrea Cossio; Andrea Biondi; Adriana Balduzzi; Francesca Lanfranconi
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.